Company intelligence / Profile preview

Avey

Ownership: Private
Development stage: Other

Overview

Avey has developed and launched an advanced AI-powered medical diagnostic platform that enables individuals to assess symptoms and receive personalized healthcare recommendations. The system is designed to improve access, accuracy, and affordability in healthcare by providing reliable alternatives to self-diagnosis via search engines. The technology is continually refined for greater accuracy and global applicability

Therapeutic areas: Other
Modalities: Non-pharmacological therapy (AI-driven digital health platform)
Industry: Digital Health Medical Devices

Beyond the preview

Go deeper on Avey.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Avey.

Explore the full profile